2100 — Manufacture of pharmaceuticals, medicinal chemical and botanical products
UN ISIC Rev. 5 2100 (Manufacture of pharmaceuticals, medicinal chemical and botanical products) classifies within economic division 21 (Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.
UNSD • v5.0
Manufacture of pharmaceuticals, medicinal chemical and botanical products
NAICS 325199
8 Exclusion Refs
Activity Scope, Operators & Exclusions
Who Uses This Code & Typical Business Models
- Active pharmaceutical ingredient (API) and finished drug makers
- Vaccine, biologic, serum, and diagnostic preparation labs
- Veterinary medicine and medicated surgical dressing manufacturers
This Class Includes
10- manufacture of medicinal active substances to be used for their pharmacological properties in the manufacture of medicaments: antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids etc.
- processing of blood
- manufacture of medicaments:
- * antisera and other blood fractions
- * vaccines
- * diverse medicaments, including homeopathic preparations
- manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments
- manufacture of medical diagnostic preparations, including pregnancy tests
- manufacture of radioactive in-vivo diagnostic substances
- manufacture of biotech pharmaceuticals
Also Includes
- manufacture of chemically pure sugars
- processing of glands and manufacture of extracts of glands etc.
- manufacture of medical impregnated wadding, gauze, bandages, dressings etc.
- preparation of botanical products (grinding, grading, milling) for pharmaceutical use
This Class Excludes (Cross-References)
8- manufacture of probiotics, see 1079
- manufacture of herb infusions (mint, vervain, chamomile etc.), see 1079
- manufacture of dental fillings and dental cement, see 3250
- manufacture of bone reconstruction cements, see 3250
- wholesale of pharmaceuticals, see 4649
- retail sale of pharmaceuticals, see 4772
- research and development for pharmaceuticals and biotech pharmaceuticals, see 7210
- packaging of pharmaceuticals, see 8292
Legislation, Licensing, Incorporation & Tax Framework
Governing Statutes & Regulations
Mandatory Permits, Licenses & Authorities
- TİTCK Manufacturing Authorization, Good Manufacturing Practice (GMP) Certificate, and Drug Marketing Authorizations
- İTS serialization integration & mandatory Qualified Person (Mesul Müdür)
- Ministry of Agriculture Veterinary Drug License for 21.20 animal formulations
Incorporation Route & Chamber Registration
- EU NACE Rev. 2.1 Framework
- Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
- United States (IRS / SBA / NAICS)
- Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization.
- United Kingdom (Companies House / HMRC)
- Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.
VAT, Withholding & Statutory Incentives
- Licensed pharmaceuticals carry 10% reduced VAT in Turkey.
- Classified as High-Technology Manufacturing: qualifies for KOSGEB Business Dev grants, Law 5746 R&D Center deductions, and Priority/Strategic Investment Incentives.
Cross-Border Regulatory Frameworks (EU / US / UK)
Chamber of Industry / Commerce + Industrial Registry (Capital Company required) — JSC/LLC structure mandatory for GMP pharmaceutical manufacturing.
Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
Classification Boundaries & Audit Risks
- Dietary supplements and vitamins belong in Div. 10 (10.89) under Food Law, not Div. 21 drugs.
- Non-medicated medical devices and surgical instruments sit in Div. 32 (32.50).
Global Classification Passport
Verified structural and concordance mappings across EU, US, UK, UN, and national registries.
Classification Hierarchy & Data Export
- C Manufacturing
- 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 210 Manufacture of pharmaceuticals, medicinal chemical and botanical products
- 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products
Frequently Asked Questions
What business activities and models fall under UN ISIC Rev. 5 2100?
2100 (Manufacture of pharmaceuticals, medicinal chemical and botanical products): manufacture of medicinal active substances to be used for their pharmacological properties in the manufacture of medicaments: antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids etc.; processing of blood; manufacture of medicaments:. Typical operators: Active pharmaceutical ingredient (API) and finished drug makers; Vaccine, biologic, serum, and diagnostic preparation labs.
What regulatory licensing and tax rules apply to 2100 across EU, US, UK, or Turkey?
EU: Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization. US: Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization. UK: Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.
What are the international classification equivalents and MCC code for 2100?
Verified concordance for 2100: US NAICS 2022: 325199 (All Other Basic Organic Chemical Manufacturing), 325411 (Medicinal and Botanical Manufacturing), 325412 (Pharmaceutical Preparation Manufacturing).
Which activities are excluded from UN ISIC Rev. 5 2100?
Official explanatory notes exclude: manufacture of probiotics, see 1079; manufacture of herb infusions (mint, vervain, chamomile etc.), see 1079; manufacture of dental fillings and dental cement, see 3250.